Clinical trials: Community Pneumonia
COVID-19
Community Perception on COVID-19 Prevention and Control
In times whereby COVID-19 is rapidly spreading, research on the epidemiological, diagnostic, clinical and social aspects of the illness has been highlighted as important as there is very limited information of this disease in all…
- Trial name
- NCT06452108
- Where
- Pakistan
- Volunteers
- 2,651 people, healthy volunteers welcome
- Sponsor
- University of Edinburgh
Community-Acquired Pneumonia (CAP), Pneumonia
PromotIng Optimal Treatment for Community-acquired PNeumonia in EmErgency Rooms
In North America, up to 5% of preschoolers develop community-acquired pneumonia (CAP) every year. Pneumonia is the second-leading reason for paediatric hospitalization in both Canada and the US; approximately 20% of children…
- Trial name
- PIONEERS (NCT07099976)
- Testing
- The novel care pathway intervention, Usual Care Alone
- Where
- 6 sites in Canada
- Volunteers
- 698 people
- Sponsor
- Jeffrey Pernica
Community Acquired Pneumonia
Adjunctive Therapy of Andrographolid Sulfonatein Community Acquired Pneumonia
Adjunctive Therapy of AndrographolidSulfonate in Community Acquired Pneumonia: A Multicenter, Randomized,Double-blinded, Placebo Controlled Clinical Trial.
- Trial name
- NCT02913118
- Testing
- Andrographolid Sulfonate Injection (AS Injection), Cephalosporin, Azithromycin, Minocycline or Doxycycline
- Where
- 16 sites in China
- Volunteers
- 462 people
- Sponsor
- Qingfeng Pharmaceutical Group
Community Acquired Pneumonia
Study to Proof the Clinical and Bacteriological Non-inferiority of Ampicillin/Amoxicillin Versus Moxifloxacin in Hospitalized Patients With Non-severe Community-acquired Pneumonia
The purpose of this study is to prove the clinical and bacteriological non-inferiority of ampicillin/amoxicillin versus moxifloxacin in hospitalized patients with non-severe community-acquired pneumonia.
- Trial name
- PENCAP (NCT00887276)
- Testing
- Moxifloxacin, Ampicillin;Amoxicillin
- Where
- 8 sites in Germany
- Volunteers
- 290 people
- Sponsor
- University of Ulm
Community Acquired Pneumonia (CAP), Pneumococcal Pneumonia
Pneumococcal Community-Acquired Pneumonia Requiring Hospitalization Among Colombian Adults
Pneumococcal Community-Acquired Pneumonia Requiring Hospitalization Among Adults in Colombia (Pneumo-CAP Colombia) This study aims to learn more about pneumococcal community-acquired pneumonia (CAP) caused by Streptococcus…
- Trial name
- PneumoCAP (NCT07354425)
- Where
- 11 sites in Colombia
- Volunteers
- 688 people
- Sponsor
- Universidad de la Sabana
Community-acquired Pneumonia
Reason Evaluation of Initial Treatment Failure in Patients With CAP
This research is to evaluate the effect of different antibiotics (Moxifloxacin Hydrochloride and Sodium Chloride Injection vs. β-lactam antibiotics for injection +/- Azithromycin for Injection) on the early deterioration or…
- Trial name
- RECAP (NCT03280004)
- Testing
- Moxifloxacin Hydrochloride and Sodium Chloride Injection
- Where
- China
- Volunteers
- 314 people
- Sponsor
- Peking Union Medical College Hospital
Community-acquired Pneumonia
Failure and Cardiovascular Events in Community-acquired Pneumonia
Although failure and mortality are the most relevant outcomes in patients with Community-acquired Pneumonia (CAP), there is little discussion in the literature on their incidence and etiology.
- Trial name
- FAILCAP (NCT01143155)
- Where
- Italy
- Volunteers
- 2,000 people
- Sponsor
- University of Milan
Community Acquired Pneumonia
Coenzyme Q10 in Pediatric Community-Acquired Pneumonia
The aim of this work is to assess the benefit of coenzyme Q10 supplementation, in addition to standard antibiotic and other supportive therapy, in the management of hospitalized children with community acquired pneumonia
- Trial name
- NCT07317440
- Testing
- oral coenzymeQ10
- Where
- Egypt
- Volunteers
- 120 people
- Sponsor
- Tanta University
Community-acquired Pneumonia, COPD Exacerbation Acute
Neuromuscular Electrical Stimulation in COPD/Community Acquired Pneumonia
In older adults hospitalized for acute medical conditions, immobility, clinical treatments, and the illness itself contribute to physical deconditioning and delirium, hospital-acquired impairments that increase risk for long-term…
- Trial name
- NCT05452226
- Testing
- neuromuscular electrical stimulation (NMES)
- Where
- United States
- Volunteers
- 7 people
- Sponsor
- University of Vermont
Heart Failure, Congestive, Pulmonary Disease, Chronic Obstructive
Capturing Outcomes of Clinical Activities Performed by a Rounding Pharmacist Practising in a Team Environment
We, the researchers, propose to link a clinical pharmacist with an internal medicine or family medicine team to provide pharmaceutical care to all patients assigned to the team.
- Conditions
- Heart Failure, Congestive, Pulmonary Disease, Chronic Obstructive, Pneumonia, Diabetes Mellitus, Type 2
- Trial name
- NCT00351676
- Testing
- Integration of a team based clinical pharmacist, Optimizing therapeutic treatments, Optimizing processes of care
- Where
- 3 sites in Canada
- Volunteers
- 452 people
- Sponsor
- University of Alberta
Multiplex Respiratory PCR Results in Diabetic Pneumonia Cases
Multiplex Respiratory PCR Results in Diabetic Pneumonia Cases
Multiplex respiratory polymerase chain reaction (PCR) test has gained wide acceptance as an alternative to conventional culture methods for the detection of the causative agent of community-acquired pneumonia (CAP).
- Trial name
- PCR (NCT06459713)
- Testing
- multiplex respiratory polymerase chain reaction test
- Where
- Turkey (Türkiye)
- Volunteers
- 151 people
- Sponsor
- Hisar Intercontinental Hospital
Community-acquired Pneumonia
Duration of Antibiotic Treatment in Community-acquired Pneumonia
International and national clinical guidelines recommend short antibiotic regimens in patients with non-severe community-acquired pneumonia (CAP) who have reached clinical stability.
- Trial name
- ADAPT (NCT05762328)
- Testing
- Reminders to the assistant clinicians of the need to adhere to clinical guidelines regarding the duration of antibiotic treatment community-acquired pneumonia
- Where
- Spain
- Volunteers
- 2,000 people
- Sponsor
- Instituto de Investigacion Sanitaria La Fe
Pneumonia
Efficacy Studies of Corticosteroid Therapy in Community-Acquired Pneumonia
The purpose of this study is to determine the efficacy of addition of corticosteroid therapy to antibiotics in patient admitted with Community-acquired pneumonia.
- Trial name
- NCT00170196
- Testing
- prednisone
- Where
- Netherlands
- Volunteers
- 216 people
- Sponsor
- Medical Center Alkmaar
Community-acquired Pneumonia
TCM Syndrome Differentiation Treatment on Discharged Elderly Patients With CAP
This study is to evaluate the efficacy and safety of TCM syndrome differentiation treatment on the rehospitalization rate of discharged elderly patients with community acquired pneumonia(CAP)and to explore its mechanism.
- Trial name
- NCT04702074
- Testing
- Traditional Chinese medicine granules
- Where
- China
- Volunteers
- 292 people
- Sponsor
- Henan University of Traditional Chinese Medicine
Pneumonia
Telithromycin, Treating Adult Outpatients With Mild to Moderate Community-acquired Pneumonia (CAP) in High Bacterial Resistance Areas
Demonstrate efficacy of telithromycin over single-agent oral antibiotics usually prescribed by local guidelines ("usual care") for treating adult outpatients with mild to moderate community-acquired pneumonia (CAP) in high…
- Trial name
- NCT00538018
- Testing
- Telithromycin
- Volunteers
- 978 people
- Sponsor
- Sanofi
Community-Acquired Pneumonia
Improved Use of Antibiotic Guidelines in Hospital Environment
The purpose of this study is to determine if the use of antibiotic guidelines and thus antibiotics can be improved through a description of possible barriers leading to tailored interventions.
- Trial name
- NCT00512772
- Where
- 2 sites in Belgium
- Volunteers
- 823 people
- Sponsor
- KU Leuven
Community-Acquired Infections, Bacterial Pneumonia
Study Comparing Tigecycline vs. Levofloxacin in Subjects Hospitalized With Community-Acquired Pneumonia
To compare the efficacy and safety of IV tigecycline to IV levofloxacin in the treatment of subjects with CAP requiring hospitalization.
- Conditions
- Community-Acquired Infections, Bacterial Pneumonia, Cross Infection
- Trial name
- NCT00081575
- Testing
- Tigecycline, Levofloxacin
- Volunteers
- 434 people
- Sponsor
- Wyeth is now a wholly owned subsidiary of Pfizer
Respiratory Tract Infections
Evaluation of the Treatment With Klacid SR in Patients With Acute Tracheitis, Tracheobronchitis and Bronchitis, Acute Exacerbation of Chronic Bronchitis and Mild Community-acquired Pneumonia in Common Clinical Practice in Ukraine
To describe the relief of symptoms, tolerability, and compliance of treatment with Klacid® sustained release (SR) at a dose of 1000 mg once daily in patients with acute tracheitis, acute tracheobronchitis, acute bronchitis, or in…
- Trial name
- KLARAINE (NCT01095978)
- Testing
- Clarithromycin (Klacid SR)
- Where
- 126 sites in Ukraine
- Volunteers
- 2,822 people
- Sponsor
- Abbott
Pneumonia, Bacterial
A Study Of Intravenous Sulopenem And Oral PF-03709270 In Community Acquired Pneumonia That Requires Hospitalization
The purpose of this study is to test if intravenous sulopenem and an oral drug, PF-03709270 are safe and effective in patients that are hospitalized with community acquired pneumonia.
- Trial name
- NCT00797108
- Testing
- sulopenem and PF-03709270, Ceftriaxone and amoxicillin/clavulanate
- Where
- 24 sites in United States, Australia and 3 more
- Volunteers
- 35 people
- Sponsor
- Pfizer
COVID 19
Prospective Hospital Registry of Patients With Suspected or Confirmed Coronavirus Infection (COVID-19) and Community-acquired Pneumonia
Coronavirus-2019 disease (COVID-19) and community-acquired pneumonia are significant problems of modern medicine. Pneumonia is the most common severe complication of COVID-19.
- Trial name
- TARGET-VIP (NCT04522076)
- Where
- 2 sites in Russia
- Volunteers
- 1,130 people
- Sponsor
- National Research Center for Preventive Medicine